Peter Gaskin

Peter Gaskin is an accomplished professional with expertise in early pharmaceutical and biotech development as well as non-clinical safety assessment. He excels in nonclinical strategy implementation from discovery to market, integrated program and project management, as well as regulatory dossier authoring and submission management. Peter has comprehensive experience in New Chemical Entities (NCEs), biologics, and Advanced Therapy Medicinal Products (ATMPs). He is a UK and European Registered Toxicologist and a member of TOPRA. Peter's specialties include program management, project management, technical and regulatory writing, line and matrix management, toxicology, metabolism, and drug development.

With a PhD from the University of Nottingham and a BSc from the University of Surrey, Peter Gaskin has a strong academic foundation in the field.

Peter has held key positions in renowned organizations, including Senior Director of Scientific Advisory Services, Director, and Associate Director at Charles River Laboratories. Previously, he served as the Principal Owner at Independent Non-clinical Consultant, Associate Director (Nonclinical) at PPD Consulting, and Principal Consultant at Aptuit Consulting Ltd. His experience also includes roles such as Head of Program Management, Program Associate Director, and Program Manager at Quintiles, as well as Senior Toxicologist at Inveresk Research and Research Assistant at ICI CTL.